The importance of anemia and its correction in the management of severe congestive heart failure

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

2000 • 737 citations

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

2002 • 721 citations

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

2001 • 705 citations

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

2001 • 654 citations

Survival of patients with a new diagnosis of heart failure: a population based study

2000 • 576 citations

Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure

2003 • 550 citations

Consensus recommendations for the management of chronic heart failure

1999 • 361 citations

Acute Precipitants of Congestive Heart Failure Exacerbations

2001 • 344 citations

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.

1993 • 304 citations

Can physicians always explain the results of clinical trials? a case study of amlodipine in heart failure

1999 • 273 citations

The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart

1994 • 218 citations

Normal Reference Laboratory Values

1998 • 209 citations

Advances in the anemia of chronic disease.

1999 • 198 citations

Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles

1994 • 147 citations

Decreased hematopoiesis in bone marrow of mice with congestive heart failure

2002 • 142 citations

The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin

1999 • 121 citations

Intravenous Ferric Saccharate as an Iron Supplement in Dialysis Patients

1996 • 104 citations

An overview of tumor necrosis factor α and the failing human heart

1999 • 95 citations

Erythropoietin and transferrin metabolism in nephrotic syndrome

2001 • 95 citations

Erythropoietin and anemia

2001 • 88 citations

Chairman's workshop report. What are The short-term and long-term consequences of anaemia in CRF patients?

1999 • 80 citations

The pathological consequences of anaemia

2001 • 77 citations

Morbidity risk assessment in the surgically anemic patient

1995 • 64 citations

Serum erythropoietin in heart failure patients treated with ACE‐inhibitors or AT₁ antagonists

2000 • 64 citations

Cardiac hypertrophy and failure in hypertension

1996 • 54 citations

Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.

2000 • 48 citations

Myocardial ischaemia in anaemic patients.

1998 • 46 citations

Effect of erythropoietin on cardiovascular diseases

2001 • 44 citations

Aggressive Therapy of Congestive Heart Failure and Associated Chronic Renal Failure with Medications and Correction of Anemia Stops or Slows the Progression of Both Diseases

2001 • 39 citations

Cited By (0)

Loading...